Experimental study demonstrates enhanced drug loading and two-stage delivery in bimodal UVM-7 silicas, indicating that shorter pores reduce blocking effects.
The capability of UVM‐7 silicas to work as supports for drug storage and delivery is investigated using ibuprofen as a model. UVM‐7 silicas are surfactant‐assisted synthesised mesoporous materials displaying a characteristic bimodal pore architecture related to their nanoparticulate texture. Strict control of the drug‐charge protocol allows the achievement of high ibuprofen loads, not only because of the availability of intra‐nanoparticle mesopores and large textural voids, but also owing to the decrease in pore‐blocking effects (with regard to related unimodal mesoporous materials such as MCM‐41) achieved through the shortening of the mesopore length. The UVM‐7/ibuprofen nanocomposites are characterised using XRD, TEM and N2 adsorption/desorption isotherms, and the drug‐delivery processes are monitored by spectrometric techniques. The bimodal porosity results in two‐stage drug‐delivery processes, which are analysed through kinetic models.
No takes yet. Share an insight, caveat, or question.
Burguete et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: